YY1AP1 Antikörper (AA 301-400)
Kurzübersicht für YY1AP1 Antikörper (AA 301-400) (ABIN720925)
Target
Alle YY1AP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 301-400
-
Homologie
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human YY1AP1/HCCA2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- YY1AP1 (YY1 Associated Protein 1 (YY1AP1))
-
Andere Bezeichnung
- YY1AP1
-
Hintergrund
-
Synonyms: HCCA1, HCCA2, Hepatocellular carcinoma susceptibility protein, Hepatocellular carcinoma-associated protein 2, YAP, YY1-associated protein 1, YY1AP, YY1AP1, YYAP1_HUMAN.
Background: Enhances transcription activation by YY1.Tissue specificity:Ubiquitous. Detected in small intestine, skeletal muscle, lung, pancreas, brain, stomach, spleen, colon and heart. Detected at very low levels in healthy liver. Highly expressed in most liver carcinomas.
-
Gen-ID
- 55249
Target
-